Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1983-05-03
1985-04-23
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514255, 514576, A61K 3118
Patent
active
045130078
ABSTRACT:
Calcium Dobesilate of the formula: ##STR1## Can be used against coronary heart disease, myocardial infarction or disturbances of the lymphatic circulation of the heart.
REFERENCES:
patent: 3436462 (1969-04-01), Esteve-Subirana
patent: 3509207 (1970-04-01), Esteve-Subirana
patent: 3764700 (1973-10-01), Esteve-Subirana
patent: 4005220 (1977-01-01), Esteve-Subirana
patent: 4038390 (1977-07-01), Esteve-Subirana
Chem. Abst. 90, 66569(g) (1979)--Van Nueten et al.
Kline, Miller and Katz: Cardiac Lymph Flow Impairment and Myocardial Fibrosis, Archives of Pathology, Cardiac Lymph Flow, pp. 86-95.
Solti, Szlavy, Gloviczki and Sebestyen, Involvement of the Cardiac Lymphostasis in the Pathogenesis of Some Arrhythmias, Progress in Lymphology, pp. 84-85.
Iwasaki, et al., American Heart Journal, Sep., 1981, pp. 324-329.
Maroko, et al., Enzymes in Cardiology: Diagnosis and Research, pp. 529-559.
A. Wade, The Extra Pharmacopoeia, Calcium Dobesilate, p. 1734, 19.
de Courten Alfred
Esteve-Soler Jose
Schulthess Adrian
Laboratoires OM SA
Robinson Douglas W.
LandOfFree
Method for treating heart disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating heart disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating heart disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36811